On August 9, WIB-San Francisco Bay Area will host a panel discussion at Nektar Therapeutics featuring women at the forefront of translational research. Transferring insights from bench to bedside is
On August 9, WIB-San Francisco Bay Area will host a panel discussion at Nektar Therapeutics featuring women at the forefront of translational research. Transferring insights from bench to bedside is a critical component of the biopharmaceutical industry’s mission, and this event is focused on demystifying translational research in the context of a lively, interactive discussion. Our expert panelists will shed light on this underexplored process, drawing from their own experiences in therapeutic areas ranging from infectious disease to cancer to rare diseases.
The panel includes our moderator, Maureen Cronin, Ph.D. (Executive Director of Informatics and Knowledge Utilization at Celgene), and panelists:
- Oranee Daniels, M.D. (CMO at Antiva Bioscience)
- Ellen Filvaroff, Ph.D. (Senior Director in Translational Development at Celgene)
- Nancy K. Pryer, Ph.D. (Vice President of Translational Sciences at BioMarin)
- Victoria Sung, Ph.D. (Director of Translational Development at Celgene)
These veteran researchers will share insights and describe the paths that led them to success in translational research. Please join us for what promises to be an exciting evening of discussion and networking!
Walk-ins are not accepted – be sure to register early!
|5:00 p.m. – 6:00 p.m.||Registration and Networking|
|6:00 p.m. – 6:15 p.m.||WIB Welcome and Introduction|
|6:15 p.m. – 8:00 p.m.||Panel Discussion and Q&A|
|8:00 p.m. – 8:30 p.m.||Networking with Panelists|
(Wednesday) 5:00 pm - 8:30 pm
455 Mission Bay Blvd, South San Francisco, CA, 94158